Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
24
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Wallace Peggy | Director | 11 | $51.0K | $0 | 2026-06-17 |
| BIOS Memory SPV I, LP | Director, 10% Owner | 34 | $2.28M | $1.1K | 2026-06-17 |
| Khattar Jack A. | Director | 8 | $0 | $0 | 2026-06-17 |
| Monia Brett P | Director | 8 | $0 | $0 | 2026-06-17 |
| RICHSTONE ELLEN B | Director | 10 | $26.6K | $0 | 2026-06-17 |
| Doyle John Brendan | Chief Financial Officer | 17 | $11.3K | $0 | 2026-05-01 |
| Caggiano Anthony | Chief Medical Officer | 19 | $11.1K | $0 | 2026-04-16 |
| Ricciardi Lisa | CEO & President | 26 | $215.6K | $0 | 2026-04-16 |
| Fletcher Aaron G.L. | Director, 10% Owner | 39 | $2.28M | $1.1K | 2025-09-19 |
| BIOS Advisors GP, LLC | Director, 10% Owner | 3 | $0 | $0 | 2025-06-18 |
| BIOS Fund III, LP | Director, 10% Owner | 2 | $0 | $0 | 2025-06-18 |
| Kreis Leslie W. | Director, 10% Owner | 2 | $0 | $0 | 2024-06-07 |
| Bios Equity Partners II, LP | Director, 10% Owner | 2 | $0 | $0 | 2024-06-07 |
| BIOS Fund I, LP | Director, 10% Owner | 5 | $99.4K | $0 | 2023-06-09 |
| BIOS Memory SPV II, LP | Director, 10% Owner | 2 | $0 | $0 | 2023-06-09 |
| BIOS Fund III QP, LP | Director, 10% Owner | 3 | $42.6K | $0 | 2022-11-28 |
| BIOS Fund I QP, LP | Director, 10% Owner | 6 | $1.84M | $0 | 2022-11-28 |
| BIOS Fund III NT, LP | 10% Owner | 3 | $99.4K | $0 | 2022-11-16 |
| Cavu Management, LP | 10% Owner | 3 | $1.80M | $0 | 2022-11-15 |
| Golden Seeds Cognition Therapeutics LLC | 10% Owner | 14 | $0 | $397 | 2022-09-27 |
| Bios Equity Partners, LP | Director, 10% Owner | 3 | $0 | $0 | 2022-06-10 |
| O'Brien James Michael | Chief Financial Officer | 3 | $60.0K | $0 | 2022-03-23 |
| Ogden CAP Associates, LLC | 10% Owner | 13 | $0 | $889 | 2021-10-13 |
| Breedlove Mark H. | Director | 11 | $0 | $141 | 2021-10-13 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| BIOS Memory SPV I, LP | Director, 10% Owner | A Award | 2026-06-17 | 2026-06-22 | 25,000 | — | $0 | 81,229 | SEC↗ |
| RICHSTONE ELLEN B | Director | A Award | 2026-06-17 | 2026-06-22 | 25,000 | — | $0 | 83,500 | SEC↗ |
| Wallace Peggy | Director | A Award | 2026-06-17 | 2026-06-22 | 25,000 | — | $0 | 111,461 | SEC↗ |
| Monia Brett P | Director | A Award | 2026-06-17 | 2026-06-22 | 25,000 | — | $0 | 73,500 | SEC↗ |
| Khattar Jack A. | Director | A Award | 2026-06-17 | 2026-06-22 | 25,000 | — | $0 | 73,500 | SEC↗ |
| Doyle John Brendan | Chief Financial Officer | F Tax w/h | 2026-05-01 | 2026-05-04 | 8,567 | $1.28 | $11.0K | 618,942 | SEC↗ |
| Caggiano Anthony | Chief Medical Officer | P Buy | 2026-04-16 | 2026-04-20 | 10,000 | $1.11 | $11.1K | 874,906 | SEC↗ |
| Ricciardi Lisa | CEO & President | P Buy | 2026-04-16 | 2026-04-20 | 9,175 | $1.10 | $10.1K | 1,715,851 | SEC↗ |
| Doyle John Brendan | Chief Financial Officer | P Buy | 2026-04-16 | 2026-04-20 | 10,000 | $1.13 | $11.3K | 627,509 | SEC↗ |
| Caggiano Anthony | Chief Medical Officer | F Tax w/h | 2026-02-15 | 2026-02-18 | 4,680 | $1.12 | $5.2K | 864,906 | SEC↗ |
| Doyle John Brendan | Chief Financial Officer | F Tax w/h | 2026-02-15 | 2026-02-18 | 1,560 | $1.12 | $1.7K | 617,509 | SEC↗ |
| Ricciardi Lisa | CEO & President | F Tax w/h | 2026-02-15 | 2026-02-18 | 5,850 | $1.12 | $6.6K | 1,706,676 | SEC↗ |
| Caggiano Anthony | Chief Medical Officer | F Tax w/h | 2026-02-04 | 2026-02-05 | 26,919 | $1.03 | $27.7K | 869,586 | SEC↗ |
| Doyle John Brendan | Chief Financial Officer | F Tax w/h | 2026-02-04 | 2026-02-05 | 26,921 | $1.03 | $27.7K | 619,069 | SEC↗ |
| Ricciardi Lisa | CEO & President | F Tax w/h | 2026-02-04 | 2026-02-05 | 51,704 | $1.03 | $53.3K | 1,712,526 | SEC↗ |
| Caggiano Anthony | Chief Medical Officer | A Award | 2026-02-03 | 2026-02-05 | 400,000 | — | $0 | 907,993 | SEC↗ |
| Caggiano Anthony | Chief Medical Officer | F Tax w/h | 2026-02-03 | 2026-02-05 | 11,488 | $1.12 | $12.9K | 896,505 | SEC↗ |
| Doyle John Brendan | Chief Financial Officer | A Award | 2026-02-03 | 2026-02-05 | 200,000 | — | $0 | 645,990 | SEC↗ |
| Ricciardi Lisa | CEO & President | A Award | 2026-02-03 | 2026-02-05 | 800,000 | — | $0 | 1,790,266 | SEC↗ |
| Ricciardi Lisa | CEO & President | F Tax w/h | 2026-02-03 | 2026-02-05 | 26,036 | $1.12 | $29.2K | 1,764,230 | SEC↗ |
| Doyle John Brendan | Chief Financial Officer | A Award | 2025-12-18 | 2025-12-22 | 30,000 | — | $0 | 455,350 | SEC↗ |
| Doyle John Brendan | Chief Financial Officer | F Tax w/h | 2025-12-18 | 2025-12-22 | 9,360 | $1.50 | $14.0K | 445,990 | SEC↗ |
| Caggiano Anthony | Chief Medical Officer | A Award | 2025-12-18 | 2025-12-22 | 65,000 | — | $0 | 528,273 | SEC↗ |
| Caggiano Anthony | Chief Medical Officer | F Tax w/h | 2025-12-18 | 2025-12-22 | 20,280 | $1.50 | $30.4K | 507,993 | SEC↗ |
| Ricciardi Lisa | CEO & President | A Award | 2025-12-18 | 2025-12-22 | 75,000 | — | $0 | 1,013,666 | SEC↗ |
| Ricciardi Lisa | CEO & President | F Tax w/h | 2025-12-18 | 2025-12-22 | 23,400 | $1.50 | $35.1K | 990,266 | SEC↗ |
| Fletcher Aaron G.L. | Director, 10% Owner | M Exercise deriv | 2025-09-19 | 2025-09-23 | 7,729 | — | $0 | 0 | SEC↗ |
| Fletcher Aaron G.L. | Director, 10% Owner | M Exercise | 2025-09-19 | 2025-09-23 | 7,729 | $0.84 | $6.5K | 56,229 | SEC↗ |
| Ricciardi Lisa | CEO & President | F Tax w/h | 2025-07-29 | 2025-07-31 | 23,400 | $0.67 | $15.7K | 938,666 | SEC↗ |
| Ricciardi Lisa | CEO & President | A Award | 2025-07-29 | 2025-07-31 | 75,000 | — | $0 | 962,066 | SEC↗ |
| Doyle John Brendan | Chief Financial Officer | F Tax w/h | 2025-07-29 | 2025-07-31 | 9,360 | $0.67 | $6.3K | 425,350 | SEC↗ |
| Doyle John Brendan | Chief Financial Officer | A Award | 2025-07-29 | 2025-07-31 | 30,000 | — | $0 | 434,710 | SEC↗ |
| Caggiano Anthony | Chief Medical Officer | A Award | 2025-07-29 | 2025-07-31 | 65,000 | — | $0 | 483,554 | SEC↗ |
| Caggiano Anthony | Chief Medical Officer | F Tax w/h | 2025-07-29 | 2025-07-31 | 20,281 | $0.67 | $13.6K | 463,273 | SEC↗ |
| BIOS Advisors GP, LLC | Director, 10% Owner | A Award | 2025-06-18 | 2025-06-20 | 34,000 | — | $0 | 48,500 | SEC↗ |
| BIOS Fund III, LP | Director, 10% Owner | A Award | 2025-06-18 | 2025-06-20 | 34,000 | — | $0 | 48,500 | SEC↗ |
| Monia Brett P | Director | A Award | 2025-06-18 | 2025-06-23 | 34,000 | — | $0 | 48,500 | SEC↗ |
| RICHSTONE ELLEN B | Director | A Award | 2025-06-18 | 2025-06-23 | 34,000 | — | $0 | 58,500 | SEC↗ |
| Wallace Peggy | Director | A Award | 2025-06-18 | 2025-06-23 | 34,000 | — | $0 | 86,461 | SEC↗ |
| Khattar Jack A. | Director | A Award | 2025-06-18 | 2025-06-23 | 34,000 | — | $0 | 48,500 | SEC↗ |
| Doyle John Brendan | Chief Financial Officer | F Tax w/h | 2025-05-01 | 2025-05-02 | 9,692 | $0.45 | $4.4K | 404,710 | SEC↗ |
| Doyle John Brendan | Chief Financial Officer | F Tax w/h | 2025-02-15 | 2025-02-18 | 1,723 | $0.59 | $1.0K | 414,402 | SEC↗ |
| Caggiano Anthony | Chief Medical Officer | F Tax w/h | 2025-02-15 | 2025-02-18 | 5,296 | $0.59 | $3.1K | 418,554 | SEC↗ |
| Ricciardi Lisa | CEO & President | F Tax w/h | 2025-02-15 | 2025-02-18 | 6,619 | $0.59 | $3.9K | 887,066 | SEC↗ |
| Ricciardi Lisa | CEO & President | A Award | 2025-02-04 | 2025-02-04 | 631,300 | — | $0 | 893,685 | SEC↗ |
| Doyle John Brendan | Chief Financial Officer | A Award | 2025-02-04 | 2025-02-04 | 295,000 | — | $0 | 416,125 | SEC↗ |
| Caggiano Anthony | Chief Medical Officer | A Award | 2025-02-04 | 2025-02-04 | 295,000 | — | $0 | 423,850 | SEC↗ |
| Ricciardi Lisa | CEO & President | F Tax w/h | 2025-02-03 | 2025-02-04 | 28,960 | $0.67 | $19.4K | 262,385 | SEC↗ |
| Caggiano Anthony | Chief Medical Officer | F Tax w/h | 2025-02-03 | 2025-02-04 | 12,779 | $0.67 | $8.6K | 128,850 | SEC↗ |
| Ricciardi Lisa | CEO & President | P Buy | 2025-01-31 | 2025-02-04 | 38,851 | $0.77 | $29.9K | 38,851 | SEC↗ |
| Monia Brett P | Director | A Award deriv | 2024-06-07 | 2024-06-11 | 8,500 | — | $0 | 8,500 | SEC↗ |
| RICHSTONE ELLEN B | Director | A Award deriv | 2024-06-07 | 2024-06-11 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Khattar Jack A. | Director | A Award deriv | 2024-06-07 | 2024-06-11 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Wallace Peggy | Director | A Award deriv | 2024-06-07 | 2024-06-11 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Bios Equity Partners II, LP | Director, 10% Owner | A Award deriv | 2024-06-07 | 2024-06-11 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Kreis Leslie W. | Director, 10% Owner | A Award deriv | 2024-06-07 | 2024-06-11 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Monia Brett P | Director | A Award | 2024-06-07 | 2024-06-11 | 8,500 | — | $0 | 14,500 | SEC↗ |
| RICHSTONE ELLEN B | Director | A Award | 2024-06-07 | 2024-06-11 | 8,500 | — | $0 | 24,500 | SEC↗ |
| Khattar Jack A. | Director | A Award | 2024-06-07 | 2024-06-11 | 8,500 | — | $0 | 14,500 | SEC↗ |
| Wallace Peggy | Director | A Award | 2024-06-07 | 2024-06-11 | 8,500 | — | $0 | 52,461 | SEC↗ |
| Bios Equity Partners II, LP | Director, 10% Owner | A Award | 2024-06-07 | 2024-06-11 | 8,500 | — | $0 | 14,500 | SEC↗ |
| Kreis Leslie W. | Director, 10% Owner | A Award | 2024-06-07 | 2024-06-11 | 8,500 | — | $0 | 14,500 | SEC↗ |
| Doyle John Brendan | Chief Financial Officer | F Tax w/h | 2024-05-01 | 2024-05-03 | 8,699 | $1.95 | $17.0K | 121,125 | SEC↗ |
| Ricciardi Lisa | CEO & President | P Buy | 2024-03-14 | 2024-03-14 | 5,700 | $1.75 | $10.0K | 291,345 | SEC↗ |
| Ricciardi Lisa | CEO & President | A Award deriv | 2024-02-15 | 2024-02-20 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Caggiano Anthony | Chief Medical Officer | A Award deriv | 2024-02-15 | 2024-02-20 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Doyle John Brendan | Chief Financial Officer | A Award deriv | 2024-02-15 | 2024-02-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Ricciardi Lisa | CEO & President | A Award | 2024-02-15 | 2024-02-20 | 75,000 | — | $0 | 285,645 | SEC↗ |
| Caggiano Anthony | Chief Medical Officer | A Award | 2024-02-15 | 2024-02-20 | 60,000 | — | $0 | 141,629 | SEC↗ |
| Doyle John Brendan | Chief Financial Officer | A Award | 2024-02-15 | 2024-02-20 | 20,000 | — | $0 | 129,824 | SEC↗ |
| Ricciardi Lisa | CEO & President | F Tax w/h | 2024-02-03 | 2024-02-09 | 27,828 | $2.29 | $63.7K | 210,645 | SEC↗ |
| Caggiano Anthony | Chief Medical Officer | F Tax w/h | 2024-02-03 | 2024-02-09 | 12,777 | $2.29 | $29.3K | 81,629 | SEC↗ |
| Fletcher Aaron G.L. | Director, 10% Owner | A Award | 2023-11-08 | 2023-11-13 | 500,095 | $1.05 | $525.1K | 500,095 | SEC↗ |
| BIOS Fund III, LP | Director, 10% Owner | A Award | 2023-11-08 | 2023-11-13 | 500,095 | $1.05 | $525.1K | 500,095 | SEC↗ |
| Khattar Jack A. | Director | A Award deriv | 2023-06-09 | 2023-06-13 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RICHSTONE ELLEN B | Director | A Award deriv | 2023-06-09 | 2023-06-13 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Wallace Peggy | Director | A Award deriv | 2023-06-09 | 2023-06-13 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Monia Brett P | Director | A Award deriv | 2023-06-09 | 2023-06-13 | 6,000 | — | $0 | 6,000 | SEC↗ |
| BIOS Fund I, LP | Director, 10% Owner | A Award deriv | 2023-06-09 | 2023-06-13 | 6,000 | — | $0 | 6,000 | SEC↗ |
| BIOS Memory SPV II, LP | Director, 10% Owner | A Award deriv | 2023-06-09 | 2023-06-13 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Khattar Jack A. | Director | A Award | 2023-06-09 | 2023-06-13 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RICHSTONE ELLEN B | Director | A Award | 2023-06-09 | 2023-06-13 | 6,000 | — | $0 | 16,000 | SEC↗ |
| Wallace Peggy | Director | A Award | 2023-06-09 | 2023-06-13 | 6,000 | — | $0 | 43,961 | SEC↗ |
| Monia Brett P | Director | A Award | 2023-06-09 | 2023-06-13 | 6,000 | — | $0 | 6,000 | SEC↗ |
| BIOS Fund I, LP | Director, 10% Owner | A Award | 2023-06-09 | 2023-06-13 | 6,000 | — | $0 | 6,000 | SEC↗ |
| BIOS Memory SPV II, LP | Director, 10% Owner | A Award | 2023-06-09 | 2023-06-13 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Doyle John Brendan | Chief Financial Officer | A Award deriv | 2023-05-01 | 2023-05-03 | 109,824 | — | $0 | 109,824 | SEC↗ |
| Doyle John Brendan | Chief Financial Officer | A Award | 2023-05-01 | 2023-05-03 | 109,824 | — | $0 | 109,824 | SEC↗ |
| Ricciardi Lisa | CEO & President | A Award deriv | 2023-02-03 | 2023-02-07 | 213,973 | — | $0 | 213,973 | SEC↗ |
| Caggiano Anthony | Chief Medical Officer | A Award deriv | 2023-02-03 | 2023-02-07 | 94,406 | — | $0 | 94,406 | SEC↗ |
| Ricciardi Lisa | CEO & President | A Award | 2023-02-03 | 2023-02-07 | 213,973 | — | $0 | 238,473 | SEC↗ |
| Caggiano Anthony | Chief Medical Officer | A Award | 2023-02-03 | 2023-02-07 | 94,406 | — | $0 | 94,406 | SEC↗ |
| RICHSTONE ELLEN B | Director | P Buy | 2022-11-29 | 2022-11-29 | 10,000 | $2.66 | $26.6K | 10,000 | SEC↗ |
| BIOS Fund III QP, LP | Director, 10% Owner | P Buy | 2022-11-28 | 2022-11-29 | 1,973 | $2.65 | $5.2K | 326,733 | SEC↗ |
| BIOS Fund III QP, LP | Director, 10% Owner | P Buy | 2022-11-28 | 2022-11-29 | 1,871 | $2.65 | $5.0K | 309,748 | SEC↗ |
| BIOS Fund III QP, LP | Director, 10% Owner | P Buy | 2022-11-28 | 2022-11-29 | 12,220 | $2.65 | $32.4K | 2,021,906 | SEC↗ |
| BIOS Fund I QP, LP | Director, 10% Owner | P Buy | 2022-11-28 | 2022-11-29 | 1,973 | $2.65 | $5.2K | 326,733 | SEC↗ |
| BIOS Fund I QP, LP | Director, 10% Owner | P Buy | 2022-11-28 | 2022-11-29 | 12,220 | $2.65 | $32.4K | 2,021,906 | SEC↗ |
| BIOS Fund I QP, LP | Director, 10% Owner | P Buy | 2022-11-28 | 2022-11-29 | 1,871 | $2.65 | $5.0K | 309,748 | SEC↗ |
| BIOS Fund III NT, LP | 10% Owner | P Buy | 2022-11-16 | 2022-11-17 | 8,722 | $1.40 | $12.2K | 324,760 | SEC↗ |
| BIOS Fund III NT, LP | 10% Owner | P Buy | 2022-11-16 | 2022-11-17 | 54,009 | $1.40 | $75.6K | 2,009,686 | SEC↗ |
| BIOS Fund III NT, LP | 10% Owner | P Buy | 2022-11-16 | 2022-11-17 | 8,269 | $1.40 | $11.6K | 307,877 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | P Buy | 2022-11-16 | 2022-11-17 | 8,722 | $1.40 | $12.2K | 324,760 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | P Buy | 2022-11-16 | 2022-11-17 | 54,009 | $1.40 | $75.6K | 2,009,686 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | P Buy | 2022-11-16 | 2022-11-17 | 8,269 | $1.40 | $11.6K | 307,877 | SEC↗ |
| Cavu Management, LP | 10% Owner | P Buy | 2022-11-15 | 2022-11-16 | 184,270 | $1.20 | $221.1K | 316,038 | SEC↗ |
| Cavu Management, LP | 10% Owner | P Buy | 2022-11-15 | 2022-11-16 | 174,700 | $1.20 | $209.6K | 299,608 | SEC↗ |
| Cavu Management, LP | 10% Owner | P Buy | 2022-11-15 | 2022-11-16 | 1,141,030 | $1.20 | $1.37M | 1,955,677 | SEC↗ |
| BIOS Fund I QP, LP | 10% Owner | P Buy | 2022-11-15 | 2022-11-16 | 184,270 | $1.20 | $221.1K | 316,038 | SEC↗ |
| BIOS Fund I QP, LP | 10% Owner | P Buy | 2022-11-15 | 2022-11-16 | 174,700 | $1.20 | $209.6K | 299,608 | SEC↗ |
| BIOS Fund I QP, LP | 10% Owner | P Buy | 2022-11-15 | 2022-11-16 | 1,141,030 | $1.20 | $1.37M | 1,955,677 | SEC↗ |
| Wallace Peggy | Director | P Buy | 2022-11-15 | 2022-11-16 | 12,500 | $1.20 | $15.0K | 37,961 | SEC↗ |
| Ricciardi Lisa | CEO & President | P Buy | 2022-11-15 | 2022-11-16 | 12,000 | $1.30 | $15.6K | 24,500 | SEC↗ |
| Wallace Peggy | Director | J Other | 2022-09-27 | 2022-09-29 | 22,461 | — | $0 | 25,461 | SEC↗ |
| Golden Seeds Cognition Therape | 10% Owner | J Other | 2022-09-27 | 2022-09-29 | 2,489,682 | — | $0 | 0 | SEC↗ |
| Khattar Jack A. | Director | A Award deriv | 2022-06-10 | 2022-06-13 | 8,335 | — | $0 | 8,335 | SEC↗ |
| Monia Brett P | Director | A Award deriv | 2022-06-10 | 2022-06-13 | 8,335 | — | $0 | 8,335 | SEC↗ |
| RICHSTONE ELLEN B | Director | A Award deriv | 2022-06-10 | 2022-06-13 | 8,335 | — | $0 | 8,335 | SEC↗ |
| Wallace Peggy | Director | A Award deriv | 2022-06-10 | 2022-06-13 | 8,335 | — | $0 | 8,335 | SEC↗ |
| Ricciardi Lisa | CEO & President | A Award deriv | 2022-06-10 | 2022-06-13 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Fletcher Aaron G.L. | Director, 10% Owner | J Other deriv | 2022-06-10 | 2022-06-14 | 8,335 | — | $0 | 11,054 | SEC↗ |
| Fletcher Aaron G.L. | Director, 10% Owner | J Other deriv | 2022-06-10 | 2022-06-14 | 2,469 | — | $0 | 8,585 | SEC↗ |
| Fletcher Aaron G.L. | Director, 10% Owner | J Other deriv | 2022-06-10 | 2022-06-14 | 2,469 | — | $0 | 3,614 | SEC↗ |
| Ricciardi Lisa | CEO & President | A Award deriv | 2022-06-10 | 2022-06-23 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Wallace Peggy | Director | A Award deriv | 2022-06-10 | 2022-06-23 | 8,335 | — | $0 | 8,335 | SEC↗ |
| Khattar Jack A. | Director | A Award deriv | 2022-06-10 | 2022-06-23 | 8,335 | — | $0 | 8,335 | SEC↗ |
| RICHSTONE ELLEN B | Director | A Award deriv | 2022-06-10 | 2022-06-23 | 8,335 | — | $0 | 8,335 | SEC↗ |
| Monia Brett P | Director | A Award deriv | 2022-06-10 | 2022-06-23 | 8,335 | — | $0 | 8,335 | SEC↗ |
| Bios Equity Partners, LP | Director, 10% Owner | J Other deriv | 2022-06-10 | 2022-06-30 | 2,469 | — | $0 | 8,585 | SEC↗ |
| Bios Equity Partners, LP | Director, 10% Owner | J Other deriv | 2022-06-10 | 2022-06-30 | 2,469 | — | $0 | 3,614 | SEC↗ |
| Bios Equity Partners, LP | Director, 10% Owner | J Other deriv | 2022-06-10 | 2022-06-30 | 8,335 | — | $0 | 11,054 | SEC↗ |
| O'Brien James Michael | Chief Financial Officer | A Award deriv | 2022-03-23 | 2022-03-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Caggiano Anthony | Chief Medical Officer | A Award deriv | 2022-03-23 | 2022-03-25 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BIOS Advisors GP, LLC | 10% Owner | J Other deriv | 2022-01-31 | 2022-02-01 | 1,145 | — | $0 | 2,719 | SEC↗ |
| BIOS Advisors GP, LLC | 10% Owner | J Other deriv | 2022-01-31 | 2022-02-01 | 1,145 | — | $0 | 1,145 | SEC↗ |
| RICHSTONE ELLEN B | Director | A Award deriv | 2021-11-01 | 2021-11-03 | 16,670 | — | $0 | 16,670 | SEC↗ |
| Caggiano Anthony | Chief Medical Officer | A Award deriv | 2021-11-01 | 2021-11-10 | 161,676 | — | $0 | 161,676 | SEC↗ |
| Fletcher Aaron G.L. | Director, 10% Owner | C Conversion | 2021-10-13 | 2022-02-01 | 1,424,014 | — | $0 | 1,424,014 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion | 2021-10-13 | 2022-02-01 | 1,424,014 | — | $0 | 1,424,014 | SEC↗ |
| Breedlove Mark H. | Director | C Conversion deriv | 2021-10-13 | 2021-10-15 | 144,928 | — | $0 | 0 | SEC↗ |
| Breedlove Mark H. | Director | C Conversion deriv | 2021-10-13 | 2021-10-15 | 118,835 | — | $0 | 0 | SEC↗ |
| Breedlove Mark H. | Director | C Conversion deriv | 2021-10-13 | 2021-10-15 | 826,278 | — | $0 | 0 | SEC↗ |
| Breedlove Mark H. | Director | C Conversion deriv | 2021-10-13 | 2021-10-15 | 301,978 | — | $0 | 0 | SEC↗ |
| Breedlove Mark H. | Director | X Exercise deriv | 2021-10-13 | 2021-10-15 | 4,354 | — | $0 | 0 | SEC↗ |
| Ogden CAP Associates, LLC | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 882,233 | — | $0 | 0 | SEC↗ |
| Ogden CAP Associates, LLC | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 1,319,408 | — | $0 | 0 | SEC↗ |
| Ogden CAP Associates, LLC | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 333,333 | — | $0 | 0 | SEC↗ |
| Ogden CAP Associates, LLC | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 4,087,046 | — | $0 | 0 | SEC↗ |
| Ogden CAP Associates, LLC | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 438,854 | — | $0 | 0 | SEC↗ |
| Ogden CAP Associates, LLC | 10% Owner | X Exercise deriv | 2021-10-13 | 2021-10-15 | 27,471 | — | $0 | 0 | SEC↗ |
| Golden Seeds Cognition Therape | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 884,058 | — | $0 | 0 | SEC↗ |
| Golden Seeds Cognition Therape | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 542,496 | — | $0 | 0 | SEC↗ |
| Golden Seeds Cognition Therape | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 4,004,181 | — | $0 | 0 | SEC↗ |
| Golden Seeds Cognition Therape | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 1,574,370 | — | $0 | 0 | SEC↗ |
| Golden Seeds Cognition Therape | 10% Owner | X Exercise deriv | 2021-10-13 | 2021-10-15 | 12,276 | — | $0 | 0 | SEC↗ |
| Golden Seeds Cognition Therape | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 0 | — | $0 | 0 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion deriv | 2021-10-13 | 2021-10-15 | 4,605,985 | — | $0 | 0 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion deriv | 2021-10-13 | 2021-10-15 | 1,355,017 | — | $0 | 0 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion deriv | 2021-10-13 | 2021-10-15 | 792,547 | — | $0 | 0 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion deriv | 2021-10-13 | 2021-10-15 | 111,504 | — | $0 | 0 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion deriv | 2021-10-13 | 2021-10-15 | 110,744 | — | $0 | 0 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion deriv | 2021-10-13 | 2021-10-15 | 1,138,040 | — | $0 | 0 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion deriv | 2021-10-13 | 2021-10-15 | 1,930,673 | — | $0 | 0 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion deriv | 2021-10-13 | 2021-10-15 | 134,626 | — | $0 | 0 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion deriv | 2021-10-13 | 2021-10-15 | 25,593 | — | $0 | 0 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion deriv | 2021-10-13 | 2021-10-15 | 158,476 | — | $0 | 0 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion deriv | 2021-10-13 | 2021-10-15 | 24,263 | — | $0 | 0 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion deriv | 2021-10-13 | 2021-10-15 | 827,275 | — | $0 | 0 | SEC↗ |
| Fletcher Aaron G.L. | Director | X Exercise deriv | 2021-10-13 | 2021-10-15 | 33,495 | — | $0 | 0 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion deriv | 2021-10-13 | 2021-10-15 | 253,256 | — | $0 | 0 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 25,593 | — | $0 | 0 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 158,476 | — | $0 | 0 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 24,263 | — | $0 | 0 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 4,605,985 | — | $0 | 0 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 1,355,017 | — | $0 | 0 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 792,547 | — | $0 | 0 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 253,256 | — | $0 | 0 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 827,275 | — | $0 | 0 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 111,504 | — | $0 | 0 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 110,744 | — | $0 | 0 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 134,626 | — | $0 | 0 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 1,930,673 | — | $0 | 0 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion deriv | 2021-10-13 | 2021-10-15 | 1,138,040 | — | $0 | 0 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | X Exercise deriv | 2021-10-13 | 2021-10-15 | 33,495 | — | $0 | 0 | SEC↗ |
| O'Brien James Michael | Chief Financial Officer | P Buy | 2021-10-13 | 2021-10-14 | 5,000 | $12.00 | $60.0K | 5,000 | SEC↗ |
| Ricciardi Lisa | CEO & President | P Buy | 2021-10-13 | 2021-10-14 | 12,500 | $12.00 | $150.0K | 12,500 | SEC↗ |
| Breedlove Mark H. | Director | C Conversion | 2021-10-13 | 2021-10-15 | 44,806 | — | $0 | 44,806 | SEC↗ |
| Breedlove Mark H. | Director | S Sale | 2021-10-13 | 2021-10-15 | 12 | $12.00 | $141 | 404,439 | SEC↗ |
| Breedlove Mark H. | Director | C Conversion | 2021-10-13 | 2021-10-15 | 4,354 | $0.03 | $131 | 404,451 | SEC↗ |
| Breedlove Mark H. | Director | C Conversion | 2021-10-13 | 2021-10-15 | 93,296 | — | $0 | 400,097 | SEC↗ |
| Breedlove Mark H. | Director | C Conversion | 2021-10-13 | 2021-10-15 | 225,281 | — | $0 | 306,801 | SEC↗ |
| Breedlove Mark H. | Director | C Conversion | 2021-10-13 | 2021-10-15 | 36,714 | — | $0 | 81,520 | SEC↗ |
| Ogden CAP Associates, LLC | 10% Owner | S Sale | 2021-10-13 | 2021-10-15 | 74 | $12.00 | $889 | 2,210,377 | SEC↗ |
| Ogden CAP Associates, LLC | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 135,679 | — | $0 | 2,182,981 | SEC↗ |
| Ogden CAP Associates, LLC | 10% Owner | X Exercise | 2021-10-13 | 2021-10-15 | 27,471 | $0.03 | $824 | 2,210,452 | SEC↗ |
| Ogden CAP Associates, LLC | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 1,263,575 | — | $0 | 2,047,302 | SEC↗ |
| Ogden CAP Associates, LLC | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 272,756 | — | $0 | 783,727 | SEC↗ |
| Ogden CAP Associates, LLC | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 103,055 | — | $0 | 510,971 | SEC↗ |
| Ogden CAP Associates, LLC | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 407,916 | — | $0 | 407,916 | SEC↗ |
| Golden Seeds Cognition Therape | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 311,706 | — | $0 | 2,489,691 | SEC↗ |
| Golden Seeds Cognition Therape | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 273,321 | — | $0 | 273,321 | SEC↗ |
| Golden Seeds Cognition Therape | 10% Owner | S Sale | 2021-10-13 | 2021-10-15 | 33 | $12.00 | $397 | 2,177,985 | SEC↗ |
| Golden Seeds Cognition Therape | 10% Owner | X Exercise | 2021-10-13 | 2021-10-15 | 12,276 | $0.03 | $368 | 2,178,019 | SEC↗ |
| Golden Seeds Cognition Therape | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 486,742 | — | $0 | 2,165,743 | SEC↗ |
| Golden Seeds Cognition Therape | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 1,237,959 | — | $0 | 1,679,001 | SEC↗ |
| Golden Seeds Cognition Therape | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 167,721 | — | $0 | 441,042 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2021-10-13 | 2021-10-15 | 144,530 | $12.00 | $1.73M | 899,905 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion | 2021-10-13 | 2021-10-15 | 158,476 | — | $0 | 755,375 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion | 2021-10-13 | 2021-10-15 | 1,424,014 | — | $0 | 1,424,014 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion | 2021-10-13 | 2021-10-15 | 418,926 | — | $0 | 418,926 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion | 2021-10-13 | 2021-10-15 | 245,029 | — | $0 | 245,029 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion | 2021-10-13 | 2021-10-15 | 78,298 | — | $0 | 78,298 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion | 2021-10-13 | 2021-10-15 | 255,765 | — | $0 | 255,765 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion | 2021-10-13 | 2021-10-15 | 34,238 | — | $0 | 34,238 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2021-10-13 | 2021-10-15 | 23,341 | $12.00 | $280.1K | 57,579 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion | 2021-10-13 | 2021-10-15 | 351,844 | — | $0 | 351,844 | SEC↗ |
| Fletcher Aaron G.L. | Director | X Exercise | 2021-10-13 | 2021-10-15 | 33,495 | $0.03 | $1.0K | 385,339 | SEC↗ |
| Fletcher Aaron G.L. | Director | S Sale | 2021-10-13 | 2021-10-15 | 90 | $12.00 | $1.1K | 385,248 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion | 2021-10-13 | 2021-10-15 | 41,620 | — | $0 | 41,620 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion | 2021-10-13 | 2021-10-15 | 24,263 | — | $0 | 65,883 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2021-10-13 | 2021-10-15 | 22,129 | $12.00 | $265.5K | 88,012 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion | 2021-10-13 | 2021-10-15 | 25,593 | — | $0 | 60,065 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion | 2021-10-13 | 2021-10-15 | 596,899 | — | $0 | 596,899 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion | 2021-10-13 | 2021-10-15 | 34,472 | — | $0 | 34,472 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | P Buy | 2021-10-13 | 2021-10-15 | 144,530 | $12.00 | $1.73M | 899,905 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 596,899 | — | $0 | 596,899 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | P Buy | 2021-10-13 | 2021-10-15 | 22,129 | $12.00 | $265.5K | 88,012 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 24,263 | — | $0 | 65,883 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 41,620 | — | $0 | 41,620 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | S Sale | 2021-10-13 | 2021-10-15 | 90 | $12.00 | $1.1K | 385,248 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | X Exercise | 2021-10-13 | 2021-10-15 | 33,495 | $0.03 | $1.0K | 385,339 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 351,844 | — | $0 | 351,844 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | P Buy | 2021-10-13 | 2021-10-15 | 23,341 | $12.00 | $280.1K | 57,579 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 34,238 | — | $0 | 34,238 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 255,765 | — | $0 | 255,765 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 78,298 | — | $0 | 78,298 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 245,029 | — | $0 | 245,029 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 418,926 | — | $0 | 418,926 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 1,424,014 | — | $0 | 1,424,014 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 25,593 | — | $0 | 60,065 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 158,476 | — | $0 | 755,375 | SEC↗ |
| BIOS Memory SPV I, LP | 10% Owner | C Conversion | 2021-10-13 | 2021-10-15 | 34,472 | — | $0 | 34,472 | SEC↗ |
| Wallace Peggy | Director | P Buy | 2021-10-13 | 2021-10-25 | 3,000 | $12.00 | $36.0K | 3,000 | SEC↗ |
| O'Brien James Michael | Chief Financial Officer | A Award deriv | 2021-10-07 | 2021-10-12 | 54,457 | — | $0 | 54,457 | SEC↗ |
| Ricciardi Lisa | CEO & President | A Award deriv | 2021-10-07 | 2021-10-12 | 290,509 | — | $0 | 290,509 | SEC↗ |
| Ricciardi Lisa | CEO & President | A Award deriv | 2021-10-07 | 2021-10-12 | 290,509 | — | $0 | 290,509 | SEC↗ |
| Ricciardi Lisa | CEO & President | A Award deriv | 2021-10-07 | 2021-10-12 | 547,965 | — | $0 | 547,965 | SEC↗ |